Angiotensin blockade therapy and survival in pancreatic cancer: a population study

BACKGROUND: Pancreatic cancer (PC) is one of the most aggressive and challenging cancer types to effectively treat, ranking as the fourth-leading cause of cancer death in the United States. We investigated if exposures to angiotensin II receptor blockers (ARBs) or angiotensin I converting enzyme (AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Keith, Scott W., Maio, Vittorio, Arafat, Hwyda A., Alcusky, Matthew, Karagiannis, Thomas, Rabinowitz, Carol, Lavu, Harish, Louis, Daniel Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819908/
https://www.ncbi.nlm.nih.gov/pubmed/35130875
http://dx.doi.org/10.1186/s12885-022-09200-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819908/
https://www.ncbi.nlm.nih.gov/pubmed/35130875
http://dx.doi.org/10.1186/s12885-022-09200-4

Ejemplares similares